FOXP3 and cancer: In fact, studies have described a negative relationship between peripheral CD4+FoxP3+ regulatory T cell levels and clinical response to adoptive immunotherapy of human cancer [37], suggesting that Tregs mediate the inhibitory effects of adoptive immunotherapy on human tumors.